A carregar...
Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
Biotherapeutics are a rapidly growing portion of the total pharmaceutical market accounting for almost one-half of recent new drug approvals. A major portion of these approvals each year are monoclonal antibodies (mAbs). During development, non-clinical pharmacology and toxicology testing of mAbs di...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6274697/ https://ncbi.nlm.nih.gov/pubmed/30469350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113685 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|